JDP2 and hydrops fetalis: Thus, the identification of hsa-mir-17-3p downregulation and JDP2 upregulation in blood in AMI patients indicates a possible role of this miR-17-3p/mRNA pair in the impairment of cardiomyocyte viability that may contribute to HF development.